PortalsOS

Related Posts

Vote to see vote counts

The nonprofit EveryCure is supported by government funding and philanthropy, aiming to find new uses for existing drugs and make them accessible to patients who need them.

The AI platform used by EveryCure evaluates 4,000 drugs against 18,000 diseases, generating scores to identify the most promising matches for further investigation. This process aims to uncover hidden treatments.

Podcast artwork
All-In with Chamath, Jaso...Sequoia’s Roelof Botha: Why Ve...

There's a huge problem with the venture industry: there's too much money. The industry invests $150 to $200 billion a year, but to make returns work, it needs to give back $700 to $800 billion a year.

The AI system used by EveryCure took 100 days to run initially but now has a 17-hour turnaround time, significantly speeding up the process of finding potential drug-disease matches.

The U.S. government is funding Every Cure to find new uses for medicines that can save money in the healthcare system.

Podcast artwork
More or LessOracle's GPU Margins, OpenAI’s...

The current AI investment is staggering, with projections indicating spending equivalent to an Apollo program every 10 months. This includes $400 billion by major tech companies this year alone.

Podcast artwork
Shawn Ryan Show#240 Dr. David Fajgenbaum - Ca...

The U.S. government and philanthropists are funding EveryCure's work to find new uses for medicines, aiming to save money in the healthcare system by using existing drugs more effectively.

Podcast artwork
The DailySunday Special: Bringing Broad...

Recording a cast album is very expensive, costing between $200,000 and $700,000. Despite the cost, producers often invest in them to keep the show alive and generate future licensing revenue.

Podcast artwork
Moonshots with Peter Diam...OpenAI vs. Grok: The Race to B...

The numbers are just staggering. The 300 million to 6 billion tokens per minute is the one that really jumps out.

Podcast artwork
The Megyn Kelly ShowTrump Brings Peace Between Isr...

If you go to csfifm.org or .com, you will see the trials that I'm now open as randomized trials. So we're now taking patients with lung cancer who failed in.